Acura Pharmaceuticals, Inc

CIK 786947 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acura Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Aug 26, 2026NT 10-Q0001104659-26-101083
Aug 20, 20268-K0001104659-26-099200
Jul 24, 20268-K0001104659-26-086651
Jun 29, 20268-K0001104659-26-078839
May 13, 2026NT 10-Q0001104659-26-059834
May 7, 20268-K0001104659-26-056748
Mar 27, 2026NT 10-K0001104659-26-036113
Mar 10, 20268-K0001104659-26-025901
Jan 20, 20268-K0001104659-26-005038
Jan 15, 202640001104659-26-004048
Jan 15, 202640001104659-26-004050
Jan 15, 202640001104659-26-004053
Dec 29, 20258-K0001104659-25-124500
Nov 21, 2025NT 10-Q0001104659-25-114929
Oct 24, 20258-K0001104659-25-101984
Sep 4, 20258-K0001104659-25-087312
Aug 19, 2025NT 10-Q0001104659-25-080172
Jul 21, 20258-K0001104659-25-069258
Jun 24, 20258-K0001104659-25-061980
May 30, 20258-K0001104659-25-054712
May 21, 20258-K0001104659-25-051289
May 14, 2025NT 10-Q0001104659-25-048204
Apr 23, 20258-K0001104659-25-037976
Mar 26, 2025NT 10-K0001104659-25-028109
Mar 4, 20258-K0001104659-25-020108